Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats

Journal of Medicinal Food

Volumn 9, Issue 4, 2006, Pages 531-536

  Farvin, K H Sabeena ^a   Anandan, R ^a   Kumar, S Hari Senthil ^a   Shiny, K S ^a   Mathew, Suseela ^a   Sankar, T V ^a   Nair, P G Viswanathan ^a  

^a CENTRAL INSTITUTE OF FISHERIES TECHNOLOGY   (India)

Author keywords

Isoprenaline; Lipid peroxidation; Lipids; Myocardial infarction; Squalene

Indexed keywords

CHOLESTEROL; FATTY ACID; ISOPRENALINE; SQUALENE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE; HEART PROTECTION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

EID: 33846215940     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.531     Document Type: Article

References (39)

1. Mackay J, Mensah AG: Atlas of Heart Disease and Stroke, World Health Organization, Geneva, 2004.
2. Krishnaswami S: Observations on serial changes in coronary artery disease in Indians. Curr Sci 1998;74:1064-1068.
3. Farvin KHS, Anandan R, Kumar SHS, Shiny KS, Sankar TV, Thankappan TK: Effect of squalene on tissue defence system in isoproterenol induced myocardial infarction in rats. Pharmacol Res 2004;50:231-236.
4. Kohno Y, Egawa Y, Itoh S: Kinetic study of quenching reaction of singlet oxygen and scavenging reaction of free radical by squalene in n-butanol. Biochim Biophys Acta 1995;1257:52-56.
5. Ko TF, Weng TM, Chiou RY: Squalene content and antioxidant activity of Terminalia catappa leaves and seeds. J Agric Food Chem 2002;50:5343-5348.
6. Qureshi AA, Lehmann JW, Peterson DM: Amaranth and its oil inhibit cholesterol biosynthesis in six-week-old female chickens. J Nutr 1996;126:1972-1978.
7. Ivashkevich SP, Apukhovskaia LI, Vendt VP: Effects of sterols having different chemical structure and squalene on osmotic resistance of erythrocytes. Biokhimiia 1981;46:1420-1425.
8. Desai KN, Wei H, Lamartiniere CA: The preventive and therapeutic potential of squalene containing compound, Roidex on tumor promotion and regression. Cancer Lett 1996;101:93-96.
9. Ikekawa J, Umeji M, Manabe T: Studies in antitumor activity of squalene and its related compounds. Yakugaku Zasshi 1986;106: 578-582.
10. Passi S, DePita O, Puddu P, Littarru GP: Lipophilic antioxidants in human sebum and aging. Free Radic Res 2002;36:471-477.
11. Richter E, Schafer SG: Effect of squalene on hexachlorobenzene (HCB) concentrations in tissue of mice. J Environ Sci Health 1982;17:195-203.
12. Chan P, Tomlinson B, Lee CB, Lee YS: Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination in elderly patients with hypercholesterolemia. J Clin Pharmacol 1996;36:422-427.
13. Farvin KHS, Anandan R, Sankar TV, Nair PGV: Protective effect of squalene against isoproterenol induced myocardial infarction in rats. J Clin Biochem Nutr 2005;37:55-60.
14. Ravichandran LV, Puvanakrishnan R, Joseph KT: Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats. Biochem Int 1990;22:387-396.
15. Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, Gupta SK: Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 2004;94:184-190.
16. Freedman DS, Gruchow HW, Anderson AJ, Rimm AA, Barboriak JJ: Relation of triglycerides levels to coronary artery diseases. The Milwaukee Cardio-vascular Registry. Am J Epidemiol 1988;127:1118-1130.
17. Goldstein JL, Brown MS: Progress in understanding the LDL receptor and HMG CoA reductase to membrane protein that regulate the plasma cholesterol. J Lipid Res 1984;25:1450-1460.
18. Namikawa K, Okazaki Y, Nishida S, Kimoto S, Akai F, Tomura T, Hashimoto S: Changes in myocardial metallothionein on isoproterenol-induced myocardial injury. Yakugaka Zasshi 1993;113:591-595.
19. Nirmala C, Puvanakrishnan R: Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 1996;159:85-93.
20. Thankappan TK: Isolation of squalene from shark liver oil. In: Seafood Safety (Surendran PK, Mathew PT, Nirmala T, Narayan N, Jose J, Boopendranath MR, Lakshmanan PT, Nair PGV, eds.), Society of Fisheries Technologists, Cochin, India, 2003, pp. 173-175.
21. Burstein M, Scholnick HR: Precipitation of chylomicron and very low density lipoprotein from human serum with sodium lauryl sulphate. Life Sci 1972;1:177-184.
22. Folch J, Lees M, Stanley GHS: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
23. Parekh AC, Jung DH: Cholestrol determination with ferric acetate-uranil acetate and sulphuric acid-ferrous sulphate reagents. Anal Chem 1970;42:1423-1427.
24. Rice EW: Triglycerides in serum. In: Standard Methods in Clinical Chemistry (Roedrick P, McDonald RP, eds.), Academic Press, New York, 1970, p. 215.
25. Horn WT, Menahan LA: A sensitive method for determination of free fatty acids in plasma. J Lipid Res 1981;122:377-381.
26. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 1925;66:375-400.
27. Bartlett GR: Phosphorous assay in column chromatography. J Biol Chem 1959;234:466-468.
28. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979;95: 351-358.
29. Joan F, Peter Z, Philip D: Cholesterol. In: Clinical Chemistry on Diagnosis and Treatments (Arnold E, Lyold L, eds.), PG Publishing, New Delhi, 1984, pp. 230-256.
30. Buring JE, O'Connor CT, Goldhaber SZ: Decreased HDL2 and HDL3 cholesterol, Apo.AI and Apo.A II and increased risk of myocardial infarction. Circulation 1992;85:22-29.
31. Ithayarasi AP, Devi CS: Effect of α-tocopherol on isoproterenol induced changes in lipids and lipoprotein profile in rats. Indian J Pharmacol 1997;29:399-404.
32. Severson DL: Regulation of lipid metabolism in adipose tissue and heart. Can J Physiol Pharmacol 1979;57:923-937.
33. Strandberg TE, Tilvis RS, Miettinen TA: Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J Lipid Res 1990;31:1637-1643.
34. Kumar SHS, Anandan R, Devaki T, Kumar MS: Cardioprotective effects of Picrorrhiza kurroa against isoproterenol induced myocardial stress in rats. Fitoterapia 2001;72:402-405.
35. Kaul S, Kapoor, NK: Reversal of changes of lipid peroxides, xanthine oxidase and SOD by cardioprotective drugs in isoproterenol-induced myocardial necrosis in rats. Indian J Exp Biol 1989;27:625-627.
36. Zhang XQ, Moore RL, Tillotson DL, Cheung JY: Calcium currents in postinfarction rat cardiac myocytes. Am J Physiol 1995;269(6 Pt 1):C1464-C1473.
37. Sreepriya M, Devaki T, Nayeem M: Effects of L-arginine pre-treatment on isoproterenol induced changes in lipid metabolism during experimental myocardial injury in rats. J Clin Biochem Nutr 1998;25:169-175.
38. Cruickshank JM, Neil-Dwyer G: β-Blocker brain concentrations in man. Eur J Clin Pharmacol 1985;28(Suppl):21-23.
39. Anandan R, Asha KK, Ammu K, Mathew S, Nair PGV: Effects of peroxidised PUFA on tissue defense system in experimentally induced myocardial infarction in rats. In: Seafood Safety (Surendran PK, Mathew PT, Thampuran N, Nambiar N, Joseph J, Boopendranath MR, Lakshmanan PT, Nair PGV, eds.), Society of Fisheries Technologists, Cochin, India, 2003, pp. 330-335.